Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations

Hoosier Cancer Research Network · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
breastcancer
breast cancer, parp inhibition + breast cancer, parp inhibitor, triple negative, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 803346
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.